Improving access to gut-directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a "smart" solution?
digital health
hypnotherapy
irritable bowel syndrome
Journal
Neurogastroenterology and motility
ISSN: 1365-2982
Titre abrégé: Neurogastroenterol Motil
Pays: England
ID NLM: 9432572
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
revised:
11
02
2023
received:
09
02
2023
accepted:
14
02
2023
pubmed:
28
2
2023
medline:
22
3
2023
entrez:
27
2
2023
Statut:
ppublish
Résumé
Gut-directed hypnotherapy (GDH) is a highly effective brain-gut behavioral therapy which is recommended in international guidelines for the treatment of irritable bowel syndrome (IBS). There is increasing recognition of the value of GDH as part of integrated care alongside medical and dietary approaches. This has led to recent innovations to widen access to GDH to meet the increasing demand. Recent advances include streamlined courses of individualized GDH, group therapy, and remote delivery. In this issue of Neurogastroenterology and Motility, Peters et al. retrospectively report outcomes of smartphone app-delivered GDH in a population with self-reported IBS. While adherence was low, those that completed smart phone-delivered GDH-achieved symptom benefit. This mini-review summarizes the current evidence-base for available modalities of GDH and discusses the current and future utility and development of mobile health applications in the digital therapeutics' era.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14554Informations de copyright
© 2023 The Authors. Neurogastroenterology & Motility published by John Wiley & Sons Ltd.
Références
Oka P, Parr H, Barberio B, Black C, Savarino E, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:908-917.
Goodoory VC, Ng CE, Black CJ, Ford AC. Impact of Rome IV irritable bowel syndrome on work and activities of daily living. Aliment Pharmacol Ther. 2022;56:844-856.
Tornkvist NT, Aziz I, Whitehead WE, et al. Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population. United European Gastroenterol J. 2021;9:1178-1188.
Hearn M, Whorwell PJ, Vasant DH. Stigma and irritable bowel syndrome: a taboo subject? Lancet Gastroenterol Hepatol. 2020;5:607-615.
Bosman MH, Weerts ZZR, Snijkers JT, et al. The socioeconomic impact of irritable bowel syndrome: an analysis of direct and indirect healthcare costs. Clin Gastroenterol Hepatol. 2023. Epub ahead of print.
Goodoory VC, Ng CE, Black CJ, Ford AC. Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom. Aliment Pharmacol Ther. 2022;56:110-120.
Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2020;69:1441-1451.
NICE. Irritable Bowel Syndrome in Adults: Diagnosis and Management. National Institute for Healthcare and Excellence Guidelines; 2008.
Vasant DH, Paine PA, Black CJ, et al. Guidelines British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70:1214-1240.
Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116:17-44.
Simren M, Ringstrom G, Bjornsson ES, Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med. 2004;66:233-238.
Whorwell PJ, Houghton LA, Taylor EE, Maxton DG. Physiological effects of emotion: assessment via hypnosis. Lancet. 1992;340:69-72.
Lea R, Houghton LA, Calvert EL, et al. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2003;17:635-642.
Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut. 1990;31:896-898.
Houghton L, Calvert E, Jackson N, Cooper P, Whorwell P. Visceral sensation and emotion: a study using hypnosis. Gut. 2002;51:701-704.
Chang L, Berman S, Mayer EA, et al. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol. 2003;98:1354-1361.
Mertz H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000;118:842-848.
Naliboff BD, Derbyshire SW, Munakata J, et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med. 2001;63:365-375.
Rainville P, Duncan GH, Price DD, Bt C, Bushnell MC. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science. 1997;277:968-971.
Gill M. Anatomy and pathophysiology of chronic pain and the impact of hypnotherapy. Sleep Hypn. 2018;20:85-90.
Simon RA, Engström M, Icenhour A, et al. On functional connectivity and symptom relief after gut-directed hypnotherapy in irritable bowel syndrome: a preliminary study. J Neurogastroenterol Motil. 2019;25:478-479.
Lowén MB, Mayer EA, Sjöberg M, et al. Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther. 2013;37:1184-1197.
Miller VCH, Morris J, Hasan SS, Archbold S, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther. 2015;41:844-855.
Hasan SS, Whorwell PJ, Miller V, Morris J, Vasant DH. Six vs 12 sessions of gut-focused hypnotherapy for irritable bowel syndrome: a randomized trial. Gastroenterology. 2021;160:2605-2607.
Lindfors P, Unge P, Nyhlin H, et al. Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome. Scand J Gastroenterol. 2012;47:414-420.
Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut. 2003;52:1623-1629.
Rexwinkel R, Vlieger A, Bovendeert J, Rutten J, Frankenhuis C, Benninga M. Long-term follow-up of gut-directed hypnotherapy self-exercises at home using CD versus individual therapy by qualified therapists in children with irritable bowel syndrome or functional abdominal pain syndrome. J Pediatr Gastroenterol Nutr. 2019;75:24-29.
Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome-the effect of hypnotherapy. Aliment Pharmacol Ther. 1996;10:91-95.
Vasant DH, Hasan SS, Cruickshanks P, Whorwell PJ. Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome. Frontline Gastroenterol. 2020;12:570-577.
Rexwinkel R, Bovendeert JF, Rutten JM, Frankenhuis C, Benninga MA, Vlieger AM. Long-term follow-up of individual therapist delivered and standardized hypnotherapy recordings in pediatric irritable bowel syndrome or functional abdominal pain. J Pediatr Gastroenterol Nutr. 2022;75:24-29.
Basnayake C, Kamm MA, Stanley A, et al. Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-Centre, randomised controlled trial. Lancet Gastroenterol Hepatol. 2020;5:890-899.
Flik CE, Laan W, Zuithoff NPA, et al. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol. 2019;4:20-31.
Lövdahl J, Törnblom H, Ringström G, Palsson OS, Simrén M. Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome. Aliment Pharmacol Ther. 2022;55:1501-1511.
Hasan SS, Pearson JS, Morris J, Whorwell PJ. Skype hypnotherapy for irritable bowel syndrome: effectiveness and comparison with face to face treatment. Int J Clin Exp Hypn. 2019;67:69-80.
Peters SL, Gibson PR, Halmos EP. Smartphone app-delivered gut-directed hypnotherapy improves symptoms of self-reported irritable bowel syndrome: a retrospective evaluation. Neurogastroenterol Motil. 2023;e14533.
Vasant DH, Whorwell PJ. Gut-focused hypnotherapy for functional gastrointestinal disorders: evidence-base, practical aspects, and the Manchester protocol. Neurogastroenterol Motil. 2019;31:e13573.
Vlieger AM, Assa A, Borrelli O, et al. Hypnotherapy in pediatric gastroenterology. J Pediatr Gastroenterol Nutr. 2023;76:9-13.
Hunt M, Miguez S, Dukas B, Onwude O, White S. Efficacy of Zemedy, a mobile digital therapeutic for the self-management of irritable bowel syndrome: crossover randomized controlled trial. JMIR Mhealth Uhealth. 2021;9:e26152.
Everitt HA, Landau S, O'Reilly G, et al. Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial. Gut. 2019;68:1613-1623.
Keefer L, Ballou SK, Drossman DA, Ringstrom G, Elsenbruch S, Ljótsson B. A Rome working team report on brain-gut behavior therapies for disorders of gut-brain interaction. Gastroenterology. 2022;162:300-315.
Donnet A-S, Hasan SS, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions. Therap Adv Gastroenterol. 2022;15:17562848221074208.
Tonkin-Crine S, Bishop FL, Ellis M, Moss-Morris R, Everitt H. Exploring patients' views of a cognitive behavioral therapy-based website for the self-management of irritable bowel syndrome symptoms. J Med Internet Res. 2013;15:e2672.
The Emerging World of Digital Therapeutics. The treatment of many physical and mental-health conditions is going digital. Nature. 2019;573:S106-S109.
Noble H, Hasan SS, Simpson V, Whorwell PJ, Vasant DH. Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice. BMJ Open Gastroenterol. 2022;9:e001039.
Vasant DH. Global prevalence of irritable bowel syndrome: time to consider factors beyond diagnostic criteria? Lancet Gastroenterol Hepatol. 2020;5:879-880.
Sasegbon A, Vasant DH. Understanding racial disparities in the care of patients with irritable bowel syndrome: the need for a unified approach. Neurogastroenterol Motil. 2021;33:e14152.
Sasegbon A, Hasan SS, Whorwell PJ, Vasant DH. Experience and clinical efficacy of gut-directed hypnotherapy in an Asian population with refractory irritable bowel syndrome. JGH Open. 2022;6:447-453.
Siah KTHMS. Hypnotherapy and IBS:time to take control of the Asian gut. J Gastroenterol Hepatol. 2022;6:445-446.
Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395-402.